Oromandibular Dystonia Revisited: A Review and a Unique Case

Journal of Oral and Maxillofacial Surgery

Volumn 66, Issue 2, 2008, Pages 379-386

  Balasubramaniam, Ramesh ^a   Rasmussen, Jared ^b   Carlson, Lyle W ^a   Van Sickels, Joseph E ^a   Okeson, Jeffrey P ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY COLLEGE OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BOTULINUM TOXIN A; BOTULINUM TOXIN B; CLONAZEPAM; IBUPROFEN; OXYCODONE; RISPERIDONE; SERTRALINE; TRIHEXYPHENIDYL; VENLAFAXINE;

ADULT; ANAMNESIS; ANXIETY DISORDER; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DYSTONIA; ENDOMETRIOSIS; HUMAN; JOINT DISLOCATION; MAJOR DEPRESSION; PAIN; STOMACH ULCER; TEMPOROMANDIBULAR JOINT DISORDER; TREATMENT FAILURE; WIRE FIXATION;

ADULT; BOTULINUM TOXIN TYPE A; BOTULINUM TOXINS; DISLOCATIONS; DYSTONIA; FACIAL MUSCLES; FACIAL PAIN; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MASTICATORY MUSCLES; NEUROMUSCULAR AGENTS; QUESTIONNAIRES; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 38049051732     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2006.11.028     Document Type: Article

References (64)

1. Tolosa E., and Marti M.J. Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): Clinical aspects. Adv Neurol 49 (1988) 73
2. Jankovic J. Etiology and differential diagnosis of blepharospasm and oromandibular dystonia. Adv Neurol 49 (1988) 103
3. Cardoso F., and Jankovic J. Peripherally induced tremor and parkinsonism. Arch Neurol 52 (1995) 263
4. Assael L.A. Maxillofacial movement disorders. In: Laskin D.M., Greene C.S., and Hylander W.L. (Eds). TMDs An Evidence-Based Approach to Diagnosis and Treatment (2006), Quintessence Publishing, Chicago, IL
5. Meige H. Les convulsions de la face: Une forme clinique de convulsions faciales, bilaterale et mediane. Rev Neurol (Paris) 21 (1910) 437
6. Derogatis L.R., Lipman R.S., Rickels K., et al. The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory. Behav Sci 19 (1974) 1
7. Defazio G., Lepore V., Abbruzzese G., et al. Reliability among neurologists in the severity assessment of blepharospasm and oromandibular dystonia: A multicenter study. Mov Disord 9 (1994) 616
8. Logroscino G., Livrea P., Anaclerio D., et al. Agreement among neurologists on the clinical diagnosis of dystonia at different body sites. J Neurol Neurosurg Psychiatry 74 (2003) 348
9. Watts M.W., Tan E.K., and Jankovic J. Bruxism and cranial-cervical dystonia: Is there a relationship?. Cranio 17 (1999) 196
10. Gray A.R., and Barker G.R. Idiopathic blepharospasm-oromandibular dystonia syndrome (Meige's syndrome) presenting as chronic temporomandibular joint dislocation. Br J Oral Maxillofac Surg 29 (1991) 97
11. Verma R.K., Gupta B.K., Kochar S.K., et al. Meige's syndrome. J Assoc Physicians India 41 (1993) 173
12. Thompson P.D., Obeso J.A., Delgado G., et al. Focal dystonia of the jaw and the differential diagnosis of unilateral jaw and masticatory spasm. J Neurol Neurosurg Psychiatry 49 (1986) 651
13. Wang A., and Jankovic J. Hemifacial spasm: Clinical findings and treatment. Muscle Nerve 21 (1998) 1740
14. Jankovic J., and Ford J. Blepharospasm and orofacial-cervical dystonia: Clinical and pharmacological findings in 100 patients. Ann Neurol 13 (1983) 402
15. Nutt J.G., Muenter M.D., Aronson A., et al. Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord 3 (1988) 188
16. Tan E.K., and Jankovic J. Botulinum toxin A in patients with oromandibular dystonia: Long-term follow-up. Neurology 53 (1999) 2102
17. Brin M.F., Comella C., and Jankovic J. Dystonia: Etiology, Clinical Features, and Treatment (2004), Lippincott Williams & Wilkins, Philadelphia, PA
18. Bakke M., Werdelin L.M., Dalager T., et al. Reduced jaw opening from paradoxical activity of mandibular elevator muscles treated with botulinum toxin. Eur J Neurol 10 (2003) 695
19. Sankhla C., Jankovic J., and Duane D. Variability of the immunologic and clinical response in dystonic patients immuno resistant to botulinum toxin injections. Mov Disord 13 (1998) 150
20. Waddy H.M., Fletcher N.A., Harding A.E., et al. A genetic study of idiopathic focal dystonias. Ann Neurol 29 (1991) 320
21. Behari M., Singh K.K., Seshadri S., et al. Botulinum toxin A in blepharospasm and hemifacial spasm. J Assoc Physicians India 42 (1994) 205
22. Tan E.K., and Jankovic J. Tardive and idiopathic oromandibular dystonia: A clinical comparison. J Neurol Neurosurg Psychiatry 68 (2000) 186
23. Singer C., and Papapetropoulos S. A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia. Parkinsonism Relat Disord 12 (2006) 115
24. Ilic T.V., Potter M., Holler I., et al. Praying-induced oromandibular dystonia. Mov Disord 20 (2005) 385
25. Evans B.K., and Jankovic J. Tuberous sclerosis and chorea. Ann Neurol 13 (1983) 106
26. The dystonias (2003), U.S. Dept. of Health and Human Services Public Health Service National Institutes of Health, Bethesda
27. Horn S., and Comella C.L. Treatment of dystonia. In: Jankovic J., and Tolosa E. (Eds). Parkinson's Disease and Movement Disorders. ed 4) (2002), Lippincott Williams & Wilkins, Philadelphia 358-364
28. Fahn S., and Jankovic J. Practical management of dystonia. Neurol Clin 2 (1984) 555
29. Vazquez-Delgado E., and Okeson J.P. Treatment of inferior lateral pterygoid muscle dystonia with zolpidem tartrate, botulinum toxin injections, and physical self-regulation procedures: A case report. Cranio 22 (2004) 325
30. Balash Y., and Giladi N. Efficacy of pharmacological treatment of dystonia: Evidence-based review including meta-analysis of the effect of botulinum toxin and other cure options. Eur J Neurol 11 (2004) 361
31. Goldman J.G., and Comella C.L. Treatment of dystonia. Clin Neuropharmacol 26 (2003) 102
32. Wessberg G. Management of oromandibular dystonia. Hawaii Dent J 34 (2003) 15
33. Bressman S.B. Dystonia update. Clin Neuropharmacol 23 (2000) 239
34. Jankovic J., and Orman J. Botulinum A toxin for cranial-cervical dystonia: A double-blind, placebo-controlled study. Neurology 37 (1987) 616
35. Poungvarin N., Devahastin V., Chaisevikul R., et al. Botulinum A toxin treatment for blepharospasm and Meige syndrome: Report of 100 patients. J Med Assoc Thai 80 (1997) 1
36. Jankovic J., and Brin M.F. Therapeutic uses of botulinum toxin. N Engl J Med 324 (1991) 1186
37. Dutton J.J. Botulinum-A toxin in the treatment of craniocervical muscle spasms: Short- and long-term, local and systemic effects. Surv Ophthalmol 41 (1996) 51
38. Zuber M., Sebald M., Bathien N., et al. Botulinum antibodies in dystonic patients treated with type A botulinum toxin: Frequency and significance. Neurology 43 (1993) 1715
39. Jankovic J., and Schwartz K. Response and immunoresistance to botulinum toxin injections. Neurology 45 (1995) 1743
40. Adler C.H., Factor S.A., Brin M., et al. Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia. Mov Disord 17 (2002) 158
41. Capelle H.H., Weigel R., and Krauss J.K. Bilateral pallidal stimulation for blepharospasm-oromandibular dystonia (Meige syndrome). Neurology 60 (2003) 2017
42. Cooper I.S. 20-year followup study of the neurosurgical treatment of dystonia musculorum deformans. Adv Neurol 14 (1976) 423
43. Krauss J.K., Toups E.G., Jankovic J., et al. Symptomatic and functional outcome of surgical treatment of cervical dystonia. J Neurol Neurosurg Psychiatry 63 (1997) 642
44. Whitney C.M. Benign essential blepharospasm. Neurologist 11 (2005) 193
45. Sankhla C., Lai E.C., and Jankovic J. Peripherally induced oromandibular dystonia. J Neurol Neurosurg Psychiatry 65 (1998) 722
46. Buysse D.J., Reynolds III C.F., Monk T.H., et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28 (1989) 193
47. Kerns R.D., Turk D.C., and Rudy T.E. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain 23 (1985) 345
48. Blanchard E.B., Jones-Alexander J., Buckley T.C., et al. Psychometric properties of the PTSD Checklist (PCL). Behav Res Ther 34 (1996) 669
49. Stein K.D., Martin S.C., Hann D.M., et al. A multidimensional measure of fatigue for use with cancer patients. Cancer Pract 6 (1998) 143
50. Carlson C.R., Bertrand P.M., Ehrlich A.D., et al. Physical self-regulation training for the management of temporomandibular disorders. J Orofac Pain 15 (2001) 47
51. Jankovic J., Vuong K.D., and Ahsan J. Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia. Neurology 60 (2003) 1186
52. Nishioka G.J., and Van Sickels J.E. Modified endaural incision for surgical access to the temporomandibular joint. J Oral Maxillofac Surg 45 (1987) 1080
53. Okeson J.P. Management of temporomandibular disorders and occlusion. (ed 5) (2003), Mosby, St. Louis
54. Wan X.H., Vuong K.D., and Jankovic J. Clinical application of botulinum toxin type B in movement disorders and autonomic symptoms. Chin Med Sci J 20 (2005) 44
55. Colosimo C., Chianese M., Giovannelli M., et al. Botulinum toxin type B in blepharospasm and hemifacial spasm. J Neurol Neurosurg Psychiatry 74 (2003) 687
56. Jankovic J. Treatment of cervical dystonia with botulinum toxin. Mov Disord 19 suppl 8 (2004) S109
57. Dolimbek B.Z., Jankovic J., and Atassi M.Z. Cross reaction of tetanus and botulinum neurotoxins A and B and the boosting effect of botulinum neurotoxins A and B on a primary anti-tetanus antibody response. Immunol Invest 31 (2002) 247
58. Dressler D., Bigalke H., and Benecke R. Botulinum toxin type B in antibody-induced botulinum toxin type A therapy failure. J Neurol 250 (2003) 967
59. Ondo W.G. Surgical therapies for dystonia. In: Brin M.F., Comella C., and Jankovic J. (Eds). Dystonia: Etiology, Clinical Features, and Treatment (2004), Lippincott Williams & Wilkins, Philadelphia
60. Laskin D.M. Myotomy for the management of recurrent and protracted mandibular dislocations. Trans Int Conf Oral Surg 4 (1973) 264
61. Miller G.A., and Murphy E.J. External pterygoid myotomy for recurrent mandibular dislocation. Review of the literature and report of a case. Oral Surg Oral Med Oral Pathol 42 (1976) 705
62. Xinkang C. Selective resection and denervation of cervical muscles in the treatment of spasmodic torticollis: Results in 60 cases. Neurosurgery 8 (1981) 680
63. Chen X., Ma A., Liang J., et al. Selective denervation and resection of cervical muscles in the treatment of spasmodic torticollis: Long-term follow-up results in 207 cases. Stereotact Funct Neurosurg 75 (2000) 96
64. Sindet-Pedersen S. Intraoral myotomy of the lateral pterygoid muscle for treatment of recurrent dislocation of the mandibular condyle. J Oral Maxillofac Surg 46 (1988) 445